Recently, the FDA issued a nuvaring label change. Apparently, a nuvaring label change was approved by the FDA Center for Drug Evaluation and Research (CDER) on October 2013. The nuvaring label change was related to Thromboembolic Disorders and Other Vascular Problems. In particular, the nuvaring label change stated the following: […] Nuvaring Label ChangeThis entry was posted in Medical Devices and tagged blood clots deep vein thrombosis FDA heart attacks label change nuvaring pulmonary embolisms strokes on March 11, 2014 by Legal Sleuth® (updated 3531 days ago)